AstraZeneca : Investor Day Biographies - MarketScreener

Investor Day 2024


Unlocking growth to 2030 and beyond


Speaker biographies




Pascal Soriot


...

Related Keywords

Japan ,Cambridge ,Cambridgeshire ,United Kingdom ,Delhi ,India ,Washington ,United States ,Netherlands ,Manchester ,Georgetown University ,District Of Columbia ,Montreal ,Quebec ,Canada ,Paris ,France General ,France ,Zagreb ,Grad ,Croatia ,Slovenia ,Pascal Is ,Stanford ,Leicestershire ,British ,America ,American ,Sharon Barr ,Anheuser Busch Inbev ,Asia Pacific ,Marc Dunoyer ,Pascal Soriot ,Roussel Uclaf ,Dave Fredrickson ,Roche Genentech ,Hoechst Marion Roussel ,Susan Galbraith ,Iskra Reic ,Andrew Barnett ,Institute Of Marketing ,Institute Of Cancer Research ,Paris University ,Astrazeneca ,University Of London ,World Economic Forum ,Sustainable Markets Initiative ,University Of Zagreb ,University Of Delhi ,University Of Leiden ,Senior Executive Team ,International Executive ,School Of Management ,Partnership For Health System Sustainability ,Healthcare Businesswoman Association Luminary ,Stanford University ,London School Of Economics ,Biopharmaceuticals Research ,York University ,Deloitte Group ,Health Systems Task ,Head Of Research ,Japan Pharmaceutical Manufacturers Association ,Genentech ,Stanford Business School ,Product Development Of Alexion ,Cambridge Cancer Centre Executive Committee ,European Federation Of Pharmaceutical Industries ,Steering Committee ,Mcgill University ,European Association Of Cancer Research Advisory Council ,Academy Of Medical Sciences ,Investor Day ,Executive Director ,Chief Executive Officer ,Veterinary Medicine ,Birthday Honours ,Health Systems Task Force ,Chief Financial Officer ,Managing Director ,Healthcare Corporate ,Investment Banking ,Citi Global Banking ,Stanford Business ,American Red Cross ,Vice President ,Executive Vice President ,Senior Vice President ,Product Development ,Astrazeneca Rare Disease ,New York University ,Healthcare Businesswoman ,Association Luminary ,Biopharmaceuticals Business Unit ,North America ,Regional Vice President ,Middle East ,European Federation ,Pharmaceutical Industries ,Pharmaceutical Research ,Executive Officer ,Chief Strategy Officer ,Rare Disease ,Global Product ,Portfolio Strategy ,Global Head ,Rare Diseases ,Oncology Business ,Oncology Business Unit ,Astrazeneca Japan ,Specialty Care ,Vice Chairman ,Associations Japan ,Japan Pharmaceutical Manufacturers ,Monitor Group ,Monitor Deloitte Group ,Oncology Research ,Cambridge Universities ,Medical Science ,Cancer Research ,Medical Sciences ,American Association ,Scientific Advisory Board ,European Association ,Cancer Research Advisory ,Immune Therapies ,Health System Sustainability ,London School ,Medical University ,Bled School ,Investor Relations ,Global Franchise Head ,Established Oncology ,Lifecycle Leader ,Chartered Institute ,